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Evidence-based publications indicating significant gen-
der-related differences in CVD diagnosis, manifestation
and treatments as well as particular problems shifted to
the female subpopulations appeared quite recently [1].
Although CVD is traditionally considered as the major
health burden of male subpopulations surprising statis-
tics have been collected for worsening the situation in
females. New trends obviously demonstrate a shifting of
the problem into healthcare of female populations: from
25 countries selected by World Health Organisation in
the years 1990-2000, more than a half (15 countries,
60 %) currently demonstrate either increase in CVD-
related death in females or, even if the rates are decreased
then less compared to men [1]:
1st group: increased CVD-related death in females
❖ Ukraine – 63%
❖ Kazakhstan – 58%
❖ Belarus – 48 %
❖ Russian Federation – 33%
❖ Romania – 20%
❖ Japan – 13%
❖ Mexico – 2%
2nd group: CVD-related death is less decreased in
females versus males
❖ Norway – 17% less
❖ Germany – 4% less
❖ Hungary – 4% less
❖ Luxemburg – 4% less
❖ USA – 4% less
❖ Italy – 2% less
❖ Portugal – 2% less
❖ Armenia – 1% less
Further, current reports (as summarised in [1]) indi-
cate that
• women experience longer stays in hospital related to
CVD and suffer greater complications and disability
than men: negative social and economical impacts
• diagnostic approaches have been created for men
but not adapted for females
• Women experience delayed care in the case of CVD
emergency
• Women with acute myocardial infarction have
higher rates of mortality than men of the same age
• Short-term mortality after coronary intervention is
higher in women than in men
• Although the coincidence of CVD with other fatal
diseases is common in women, consistent data do not
exist to recognise co-morbidities by patient profiling.
In this context it becomes clear, why women have been
reported to consume more hospital resources than men
[2]. Those statistics have been collected for CVD in gen-
eral but, the particular significance is reported for diag-
nosed atrial fibrillation, heart failure and acute myocardial
infarction [1,2]. Hence, the American National Hospital
Discharge Survey reports stable rates of hospital admission
for men versus permanently increasing ones for the age-
matched women with diagnosed heart failure [3]: the
female gender-specific increase comprises about 19% in
North America since 1990. Further, high risk of stroke as
the secondary complication is the gender particularity
acknowledged in women diagnosed with atrial fibrillation,
in contrast to none of the predisposition as observed in
men [4]. Delayed recognition of the mounting problems
creates a consequent delay in covering multifaceted
knowledge deficits accumulated in CVD-related female
healthcare which societies around the world are currently
facing. Consequently there is an urgent need to elaborate
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the targeted measures forcing the improvement. The
recommendations might be proposed as follows:
1. identify deficits that altogether have resulted in cur-
rent unsatisfactory situation;
2. analyse rapidly worsening versus improving regional
healthcare situations and identify the most specific parti-
cularities of both;
3. elaborate effective strategies for covering the recog-
nised deficits at all levels of stakeholders that should be
obligatory involved in the process of reorganisation
including applicative science, social, economical and
political levels;
4. consider to force the practical implementation of
innovative approaches in predictive diagnostics and tar-
geted prevention that are rapidly developing in pre-clinical
trials;
5. create/ readdress sufficient budgets for educational
measures, training purposes and staffing the experts
essentially involved in the field.
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